data_1irs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1irs _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.062 -0.718 . . . . 8.3200000000000003 109.062 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 166.28 -63.17 0.22 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.585 -1.406 . . . . 5.25 109.585 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -83.94 47.1 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.5 2.8 . . . . 5.29 110.979 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.16 61.92 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.77 -1.206 . . . . 2.3199999999999998 109.243 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -62.32 131.11 48.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 109.492 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -70.49 -54.26 12.97 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.225 -0.922 . . . . 1.8999999999999999 109.166 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.431 ' HB3' ' CZ3' ' A' ' 164' ' ' TRP . 1.1 mm-40 -123.42 164.52 18.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 1.1499999999999999 109.442 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.617 HG11 ' SG ' ' A' ' 186' ' ' CYS . 5.7 t -149.16 128.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.129 -0.982 . . . . 1.29 109.842 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' A' ' 162' ' ' GLU . 19.2 m-90 -124.34 159.63 29.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.23999999999999999 109.631 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -118.01 116.9 27.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 2.27 108.677 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.623 HG23 ' SD ' ' A' ' 238' ' ' MET . 28.4 m -128.35 174.26 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.97 -1.081 . . . . 1.1699999999999999 110.45 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 3.7 mm -119.12 106.01 18.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.356 -0.979 . . . . 1.1599999999999999 108.356 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -45.06 157.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.601 0.715 . . . . 1.3500000000000001 110.747 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -131.82 136.32 28.18 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.309 -0.997 . . . . 1.54 108.309 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.61 89.87 0.72 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.366 2.044 . . . . 1.25 110.727 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -66.31 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 1.3999999999999999 109.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -137.39 -82.55 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.131 -1.188 . . . . 0.56999999999999995 110.131 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.3 mt -53.06 -29.64 31.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -1.092 . . . . 1.1599999999999999 109.954 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -90.12 51.23 3.43 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.67 -1.372 . . . . 0.40000000000000002 109.67 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -150.05 -45.21 0.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -1.079 . . . . 1.8600000000000001 109.154 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.2 m -85.94 -38.21 18.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 1.52 109.023 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 -4.14 58.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.355 -0.841 . . . . 1.3799999999999999 110.146 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 8.1 t30 68.15 48.55 0.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 2.27 110.278 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.37 90.91 3.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 1.1399999999999999 109.054 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.1 pt -154.24 168.79 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 1.29 109.647 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.25 -150.87 17.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.456 -1.458 . . . . 0.32000000000000001 109.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 1.5 mt -103.06 113.09 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 1.45 109.268 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -118.63 -174.8 2.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 2.1899999999999999 109.828 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -140.3 124.5 17.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 2.6699999999999999 109.231 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.01 91.76 7.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 1.1399999999999999 109.481 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.617 ' SG ' HG11 ' A' ' 163' ' ' VAL . 62.4 m -87.93 110.12 20.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.152 -0.967 . . . . 1.7 109.473 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.81 113.07 17.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 1.21 109.363 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 m -99.16 46.08 0.99 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 1.46 109.041 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 190' ' ' LYS . 1.9 p 38.61 28.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.268 0.47 . . . . 1.71 112.268 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.624 ' HD3' ' SD ' ' A' ' 260' ' ' MET . 0.5 OUTLIER 169.35 -34.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.244 -1.021 . . . . 2.04 108.244 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.8 p -129.7 125.72 36.62 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.247 -0.981 . . . . 1.1399999999999999 110.427 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 155.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 1.0600000000000001 109.253 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 103.38 4.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.79000000000000004 110.536 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -82.24 93.3 7.08 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.22 -0.925 . . . . 2.1299999999999999 108.746 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.2 t -96.09 137.24 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 1.1000000000000001 110.0 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 135.29 36.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 1.46 109.109 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -29.96 68.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 1.77 109.737 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.52 37.11 1.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 3.0299999999999998 109.648 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -134.79 -164.62 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.128 -0.983 . . . . 1.8400000000000001 109.469 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.27 -54.78 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 3.8300000000000001 109.408 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.71 161.01 17.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 1.24 109.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -54.71 153.32 6.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 1.0700000000000001 109.443 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -99.86 -59.34 1.73 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 1.04 109.611 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.67 92.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 1.1299999999999999 109.58 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.36 98.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 1.2 109.132 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.95 -178.75 3.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 1.1599999999999999 109.434 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -128.55 145.84 51.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.291 -0.881 . . . . 2.1499999999999999 109.526 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.601 HD23 ' SD ' ' A' ' 257' ' ' MET . 12.5 mt -68.34 -25.8 65.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 1.0900000000000001 109.5 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.444 ' SD ' ' HE2' ' A' ' 264' ' ' PHE . 0.0 OUTLIER -69.12 -13.96 62.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.095 -1.003 . . . . 2.23 110.491 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -103.4 -15.66 15.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 2.2599999999999998 110.116 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 53.0 mt -74.89 113.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.843 -1.16 . . . . 1.22 109.498 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -56.99 -49.56 75.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 2.7000000000000002 108.799 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -161.48 175.69 11.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.622 -0.674 . . . . 2.6899999999999999 109.294 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' CYS . . . . . 0.611 ' SG ' ' HE2' ' A' ' 257' ' ' MET . 0.1 OUTLIER -143.59 120.23 11.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 1.3999999999999999 108.952 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 222' ' ' PHE . . . -107.8 147.44 16.43 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.686 -1.245 . . . . 0.93999999999999995 110.669 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.517 ' CE1' ' CD2' ' A' ' 250' ' ' HIS . 3.6 p-80 -130.55 67.65 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.212 -1.032 . . . . 2.3300000000000001 108.212 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 18.6 t -64.14 90.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.76 -0.587 . . . . 1.8600000000000001 110.602 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 64.01 -88.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.452 -0.78 . . . . 1.98 110.259 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -111.72 -21.44 11.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.722 -1.236 . . . . 1.8300000000000001 110.342 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -78.43 112.72 15.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.992 -1.067 . . . . 2.1699999999999999 109.681 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -109.28 80.85 1.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.992 -0.744 . . . . 2.1800000000000002 108.992 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.422 ' CE2' ' HA3' ' A' ' 215' ' ' GLY . 38.0 p90 -87.92 161.21 17.58 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.135 -0.978 . . . . 2.21 110.14 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 1.2 mt -133.15 105.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.389 -0.82 . . . . 1.9399999999999999 109.464 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -67.92 126.33 29.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 1.27 109.324 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.92 151.0 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.518 -0.739 . . . . 1.0600000000000001 109.321 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -125.5 -148.1 7.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.696 -1.362 . . . . 0.81999999999999995 109.696 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -61.1 167.2 3.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -1.117 . . . . 5.7199999999999998 109.535 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.6 12.55 8.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 2.3599999999999999 110.397 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.12 143.57 26.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.782 -1.199 . . . . 1.1599999999999999 109.128 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 5.8 t -53.71 -27.02 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 1.24 109.707 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 37.3 p -107.41 -31.57 8.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 1.7 109.472 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . 118.88 -160.48 14.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.44 -1.464 . . . . 0.42999999999999999 109.44 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.68 134.86 24.86 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.952 2.435 . . . . 1.1100000000000001 109.935 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 161.09 -147.26 13.67 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.182 -1.567 . . . . 0.27000000000000002 109.182 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.13 145.68 18.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.209 -1.171 . . . . 1.3600000000000001 109.658 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -114.05 87.5 2.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 2.2000000000000002 109.193 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.414 ' CD2' ' HB3' ' A' ' 222' ' ' PHE . 29.1 m95 -79.91 154.04 28.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.5 109.918 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.623 ' SD ' HG23 ' A' ' 166' ' ' VAL . 13.3 ptp -160.52 176.93 11.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 1.9199999999999999 109.116 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -128.94 144.51 51.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 2.0 109.838 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.4 m -107.86 -163.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 1.0900000000000001 109.345 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.08 -39.11 75.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 1.27 109.731 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -171.81 -146.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 2.1699999999999999 109.185 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -91.74 22.1 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.601 -1.312 . . . . 1.8700000000000001 110.253 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.36 -49.65 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.938 -1.101 . . . . 1.1200000000000001 108.88 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.33 -25.79 38.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 1.1100000000000001 108.75 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -78.43 -42.72 29.21 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.468 -0.938 . . . . 1.0900000000000001 108.468 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.22 -5.43 51.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 2.0299999999999998 109.216 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.76 -31.95 12.39 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.141 -0.975 . . . . 1.71 108.551 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' MET . . . . . . . . . . . . . 6.9 ptm -87.41 -22.97 24.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.546 -0.722 . . . . 1.23 109.457 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' HIS . . . . . 0.517 ' CD2' ' CE1' ' A' ' 216' ' ' HIS . 0.0 OUTLIER -79.58 -31.93 41.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 2.3500000000000001 109.417 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 250' ' ' HIS . 5.4 mt-10 -79.12 -34.37 43.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 2.1200000000000001 109.563 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.0 m -78.02 -30.47 49.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 1.1000000000000001 109.461 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.63 -27.32 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 1.1399999999999999 109.621 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.89 -28.57 64.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 2.1000000000000001 109.519 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -78.06 -40.38 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 2.0099999999999998 109.666 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.54 -49.52 73.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 1.28 109.34 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' MET . . . . . 0.615 ' SD ' ' OD1' ' B' ' 494' ' ' ASN . 6.4 mtm -63.61 -37.74 88.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 1.55 109.345 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -26.65 68.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 4.1299999999999999 109.371 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -76.18 -23.22 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 109.728 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 190' ' ' LYS . 0.3 OUTLIER -83.09 -58.11 2.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 1.22 109.67 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -36.13 78.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.064 -1.023 . . . . 1.3899999999999999 109.785 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.66 -39.12 58.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 1.74 109.903 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.73 26.36 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 2.7200000000000002 109.585 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . 0.444 ' HE2' ' SD ' ' A' ' 209' ' ' MET . 0.2 OUTLIER -81.13 -70.49 0.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.138 -0.976 . . . . 5.0099999999999998 109.478 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 266' ' ' PRO . 0.0 OUTLIER 171.37 145.98 0.14 Allowed Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 108.7 -0.852 . . . . 7.79 108.7 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 265' ' ' ARG . 46.0 Cg_exo -55.68 -152.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 123.543 2.829 . . . . 6.1799999999999997 110.855 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.678 -1.264 . . . . 10.77 109.38 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 489' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.57 0.7 . . . . 1.6000000000000001 109.491 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 490' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.82 115.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 1.2 108.907 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 491' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.84 158.53 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 1.48 110.049 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 492' ' ' ALA . . . . . . . . . . . . . . . -133.48 -176.39 4.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 1.25 108.966 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 493' ' ' GLY . . . . . . . . . . . . . . . -132.38 166.1 23.47 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.502 -1.332 . . . . 0.91000000000000003 109.958 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 494' ' ' ASN . . . . . 0.615 ' OD1' ' SD ' ' A' ' 257' ' ' MET . 1.1 t30 -109.24 113.37 58.81 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.441 -1.035 . . . . 0.73999999999999999 108.834 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 495' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.31 -38.9 2.36 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.575 2.183 . . . . 0.40999999999999998 111.221 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 496' ' ' ALA . . . . . . . . . . . . . . . -75.39 -0.73 20.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.038 -1.039 . . . . 1.1399999999999999 111.494 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 497' ' ' PTR . . . . . 0.405 ' HB3' ' HB3' ' B' ' 494' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 498' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 72.84 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 3.52 110.433 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 499' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 120.549 -1.344 . . . . 2.8300000000000001 109.554 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.754 ' CE ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.062 -0.718 . . . . 7.9500000000000002 109.062 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 166.28 -63.17 0.22 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.585 -1.406 . . . . 4.9299999999999997 109.585 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -83.94 47.1 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.5 2.8 . . . . 4.6100000000000003 110.979 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.754 ' HB2' ' CE ' ' A' ' 156' ' ' MET . . . -93.16 61.92 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.77 -1.206 . . . . 1.8200000000000001 109.243 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -62.32 131.11 48.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 1.48 109.492 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -70.49 -54.26 12.97 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.225 -0.922 . . . . 1.3799999999999999 109.166 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.79 ' OE2' HG21 ' A' ' 252' ' ' THR . 1.1 mm-40 -123.42 164.52 18.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 1.1499999999999999 109.442 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.658 HG13 ' SG ' ' A' ' 186' ' ' CYS . 5.7 t -149.16 128.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.129 -0.982 . . . . 0.58999999999999997 109.842 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 162' ' ' GLU . 19.2 m-90 -124.34 159.63 29.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.23000000000000001 109.631 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -118.01 116.9 27.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 1.8100000000000001 108.677 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.698 ' C ' HD13 ' A' ' 167' ' ' ILE . 28.4 m -128.35 174.26 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.97 -1.081 . . . . 0.46000000000000002 110.45 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.778 HD12 HG23 ' A' ' 182' ' ' ILE . 3.7 mm -119.12 106.01 18.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.356 -0.979 . . . . 0.40999999999999998 108.356 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 183' ' ' TYR . 1.2 mm? -45.06 157.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.601 0.715 . . . . 0.73999999999999999 110.747 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 169' ' ' LYS . 2.7 tppt? -131.82 136.32 28.18 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.309 -0.997 . . . . 0.96999999999999997 108.309 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.61 89.87 0.72 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.366 2.044 . . . . 0.81999999999999995 110.727 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -66.31 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.73999999999999999 109.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -137.39 -82.55 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.131 -1.188 . . . . 0.38 110.131 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.603 HD13 ' CZ ' ' A' ' 236' ' ' PHE . 12.3 mt -53.06 -29.64 31.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -1.092 . . . . 0.34000000000000002 109.954 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -90.12 51.23 3.43 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.67 -1.372 . . . . 0.40000000000000002 109.67 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -150.05 -45.21 0.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -1.079 . . . . 1.79 109.154 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.2 m -85.94 -38.21 18.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 1.1100000000000001 109.023 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.509 ' HB2' HD12 ' A' ' 179' ' ' LEU . 0.3 OUTLIER -89.23 -4.14 58.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.355 -0.841 . . . . 0.87 110.146 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 8.1 t30 68.15 48.55 0.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 1.97 110.278 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 177' ' ' LYS . 1.9 mt -106.37 90.91 3.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.39000000000000001 109.054 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 179' ' ' LEU . 10.1 pt -154.24 168.79 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.56000000000000005 109.647 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.25 -150.87 17.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.456 -1.458 . . . . 0.31 109.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.778 HG23 HD12 ' A' ' 167' ' ' ILE . 1.5 mt -103.06 113.09 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.77000000000000002 109.268 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.519 ' HB2' HD23 ' A' ' 168' ' ' LEU . 23.8 m-85 -118.63 -174.8 2.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 1.27 109.828 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -140.3 124.5 17.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 2.25 109.231 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 253' ' ' ILE . 1.5 tp -84.01 91.76 7.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.28000000000000003 109.481 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.658 ' SG ' HG13 ' A' ' 163' ' ' VAL . 62.4 m -87.93 110.12 20.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.152 -0.967 . . . . 1.28 109.473 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 253' ' ' ILE . 21.9 tp -79.81 113.07 17.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.51000000000000001 109.363 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 m -99.16 46.08 0.99 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.76000000000000001 109.041 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 190' ' ' LYS . 1.9 p 38.61 28.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.268 0.47 . . . . 1.3600000000000001 112.268 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.651 ' HD3' ' SD ' ' A' ' 260' ' ' MET . 0.5 OUTLIER 169.35 -34.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.244 -1.021 . . . . 1.53 108.244 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.8 p -129.7 125.72 36.62 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.247 -0.981 . . . . 0.40999999999999998 110.427 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.884 HD12 HD11 ' A' ' 211' ' ' ILE . 22.5 mt -80.11 155.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.28999999999999998 109.253 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 103.38 4.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.32000000000000001 110.536 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.76 ' O ' ' HB3' ' A' ' 203' ' ' ALA . 19.9 m-85 -82.24 93.3 7.08 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.22 -0.925 . . . . 1.23 108.746 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 202' ' ' ALA . 8.2 t -96.09 137.24 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.26000000000000001 110.0 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 135.29 36.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.96999999999999997 109.109 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.469 ' CD1' HG22 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -59.34 -29.96 68.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 1.1599999999999999 109.737 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.52 37.11 1.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 2.5899999999999999 109.648 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -134.79 -164.62 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.128 -0.983 . . . . 1.5 109.469 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.27 -54.78 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 3.8300000000000001 109.408 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.71 161.01 17.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.57999999999999996 109.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HA ' HG22 ' A' ' 195' ' ' VAL . . . -54.71 153.32 6.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.31 109.443 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 194' ' ' PHE . . . -99.86 -59.34 1.73 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.28000000000000003 109.611 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.67 92.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.39000000000000001 109.58 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.537 ' O ' HG21 ' A' ' 230' ' ' VAL . 60.7 t -79.36 98.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.46999999999999997 109.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.95 -178.75 3.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.38 109.434 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -128.55 145.84 51.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.291 -0.881 . . . . 1.55 109.526 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.643 HD22 ' SD ' ' A' ' 257' ' ' MET . 12.5 mt -68.34 -25.8 65.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.28999999999999998 109.5 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.444 ' SD ' ' HE2' ' A' ' 264' ' ' PHE . 0.0 OUTLIER -69.12 -13.96 62.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.095 -1.003 . . . . 1.6200000000000001 110.491 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -103.4 -15.66 15.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 1.6899999999999999 110.116 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.884 HD11 HD12 ' A' ' 192' ' ' ILE . 53.0 mt -74.89 113.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.843 -1.16 . . . . 0.55000000000000004 109.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -56.99 -49.56 75.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 2.27 108.799 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.414 ' HD2' HD11 ' B' ' 491' ' ' ILE . 12.6 ptt180 -161.48 175.69 11.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.622 -0.674 . . . . 2.2000000000000002 109.294 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' CYS . . . . . 0.754 ' O ' ' HB3' ' B' ' 492' ' ' ALA . 0.1 OUTLIER -143.59 120.23 11.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 1.0600000000000001 108.952 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 222' ' ' PHE . . . -107.8 147.44 16.43 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.686 -1.245 . . . . 0.40999999999999998 110.669 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.64 ' HE1' ' HB2' ' B' ' 492' ' ' ALA . 3.6 p-80 -130.55 67.65 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.212 -1.032 . . . . 1.54 108.212 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 18.6 t -64.14 90.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.76 -0.587 . . . . 1.3999999999999999 110.602 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 246' ' ' ALA . 2.7 mt-10 64.01 -88.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.452 -0.78 . . . . 1.98 110.259 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -111.72 -21.44 11.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.722 -1.236 . . . . 1.1299999999999999 110.342 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -78.43 112.72 15.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.992 -1.067 . . . . 1.27 109.681 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.447 ' CZ ' HD11 ' A' ' 223' ' ' ILE . 13.1 t80 -109.28 80.85 1.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.992 -0.744 . . . . 1.27 108.992 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 237' ' ' TRP . 38.0 p90 -87.92 161.21 17.58 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.135 -0.978 . . . . 1.3 110.14 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.447 HD11 ' CZ ' ' A' ' 221' ' ' PHE . 1.2 mt -133.15 105.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.389 -0.82 . . . . 1.26 109.464 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -67.92 126.33 29.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 1.27 109.324 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.92 151.0 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.518 -0.739 . . . . 0.22 109.321 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -125.5 -148.1 7.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.696 -1.362 . . . . 0.81999999999999995 109.696 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -61.1 167.2 3.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -1.117 . . . . 5.0899999999999999 109.535 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.6 12.55 8.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 2.0 110.397 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 232' ' ' GLY . . . -92.12 143.57 26.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.782 -1.199 . . . . 0.5 109.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 205' ' ' VAL . 5.8 t -53.71 -27.02 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.66000000000000003 109.707 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 37.3 p -107.41 -31.57 8.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 1.1299999999999999 109.472 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 229' ' ' ALA . . . 118.88 -160.48 14.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.44 -1.464 . . . . 0.35999999999999999 109.44 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.68 134.86 24.86 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.952 2.435 . . . . 0.70999999999999996 109.935 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 161.09 -147.26 13.67 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.182 -1.567 . . . . 0.23000000000000001 109.182 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.13 145.68 18.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.209 -1.171 . . . . 1.3600000000000001 109.658 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.603 ' CZ ' HD13 ' A' ' 173' ' ' LEU . 33.5 m-85 -114.05 87.5 2.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 1.27 109.193 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.433 ' CD2' ' HB3' ' A' ' 222' ' ' PHE . 29.1 m95 -79.91 154.04 28.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.46000000000000002 109.918 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.67 ' SD ' HG21 ' A' ' 166' ' ' VAL . 13.3 ptp -160.52 176.93 11.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 1.51 109.116 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -128.94 144.51 51.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 1.52 109.838 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 242' ' ' ASP . 14.4 m -107.86 -163.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 109.345 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.08 -39.11 75.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 1.27 109.731 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.469 ' H ' HG23 ' A' ' 240' ' ' VAL . 4.4 t0 -171.81 -146.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 2.1699999999999999 109.185 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -91.74 22.1 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.601 -1.312 . . . . 1.45 110.253 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.36 -49.65 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.938 -1.101 . . . . 0.46000000000000002 108.88 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.33 -25.79 38.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 0.31 108.75 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 218' ' ' GLU . . . -78.43 -42.72 29.21 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.468 -0.938 . . . . 0.31 108.468 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.22 -5.43 51.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 1.8300000000000001 109.216 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.76 -31.95 12.39 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.141 -0.975 . . . . 1.01 108.551 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' MET . . . . . . . . . . . . . 6.9 ptm -87.41 -22.97 24.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.546 -0.722 . . . . 0.52000000000000002 109.457 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' HIS . . . . . 0.548 ' O ' HD23 ' A' ' 254' ' ' LEU . 0.0 OUTLIER -79.58 -31.93 41.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 1.3999999999999999 109.417 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -79.12 -34.37 43.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 2.1200000000000001 109.563 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.79 HG21 ' OE2' ' A' ' 162' ' ' GLU . 6.0 m -78.02 -30.47 49.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.37 109.461 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.932 HD11 HD13 ' A' ' 187' ' ' LEU . 0.4 OUTLIER -82.63 -27.32 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.42999999999999999 109.621 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 250' ' ' HIS . 1.6 mm? -70.89 -28.57 64.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 1.45 109.519 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -78.06 -40.38 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 2.0099999999999998 109.666 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.445 ' HB3' HD21 ' A' ' 187' ' ' LEU . . . -63.54 -49.52 73.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.56000000000000005 109.34 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' MET . . . . . 0.643 ' SD ' HD22 ' A' ' 208' ' ' LEU . 6.4 mtm -63.61 -37.74 88.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 1.1299999999999999 109.345 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -26.65 68.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 3.6400000000000001 109.371 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -76.18 -23.22 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.42999999999999999 109.728 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' MET . . . . . 0.651 ' SD ' ' HD3' ' A' ' 190' ' ' LYS . 0.3 OUTLIER -83.09 -58.11 2.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 1.1499999999999999 109.67 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -36.13 78.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.064 -1.023 . . . . 0.88 109.785 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.66 -39.12 58.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 1.74 109.903 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.73 26.36 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 2.7200000000000002 109.585 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PHE . . . . . 0.444 ' HE2' ' SD ' ' A' ' 209' ' ' MET . 0.2 OUTLIER -81.13 -70.49 0.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.138 -0.976 . . . . 4.1399999999999997 109.478 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 266' ' ' PRO . 0.0 OUTLIER 171.37 145.98 0.14 Allowed Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 108.7 -0.852 . . . . 7.0700000000000003 108.7 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 265' ' ' ARG . 46.0 Cg_exo -55.68 -152.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 123.543 2.829 . . . . 5.6200000000000001 110.855 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.678 -1.264 . . . . 10.140000000000001 109.38 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 489' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.57 0.7 . . . . 1.04 109.491 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 490' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.82 115.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.85999999999999999 108.907 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 491' ' ' ILE . . . . . 0.493 HD13 ' O ' ' B' ' 492' ' ' ALA . 0.0 OUTLIER -126.84 158.53 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.77000000000000002 110.049 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 492' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 214' ' ' CYS . . . -133.48 -176.39 4.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 1.25 108.966 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 493' ' ' GLY . . . . . . . . . . . . . . . -132.38 166.1 23.47 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.502 -1.332 . . . . 0.71999999999999997 109.958 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 494' ' ' ASN . . . . . 0.615 ' OD1' ' SD ' ' A' ' 257' ' ' MET . 1.1 t30 -109.24 113.37 58.81 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.441 -1.035 . . . . 0.73999999999999999 108.834 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 495' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.31 -38.9 2.36 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.575 2.183 . . . . 0.34999999999999998 111.221 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 496' ' ' ALA . . . . . 0.484 ' CB ' ' HE3' ' A' ' 260' ' ' MET . . . -75.39 -0.73 20.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.038 -1.039 . . . . 0.47999999999999998 111.494 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 497' ' ' PTR . . . . . 0.445 ' HB3' ' HB3' ' B' ' 494' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 498' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 72.84 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 2.8500000000000001 110.433 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 499' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 120.549 -1.344 . . . . 2.79 109.554 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.754 ' CE ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.062 -0.718 . . . . 7.95 109.062 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 166.28 -63.17 0.22 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.585 -1.406 . . . . 4.93 109.585 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -83.94 47.1 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.5 2.8 . . . . 4.61 110.979 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.754 ' HB2' ' CE ' ' A' ' 156' ' ' MET . . . -93.16 61.92 3.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.77 -1.206 . . . . 1.82 109.243 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -62.32 131.11 48.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 1.48 109.492 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -70.49 -54.26 12.97 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.225 -0.922 . . . . 1.38 109.166 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.79 ' OE2' HG21 ' A' ' 252' ' ' THR . 1.1 mm-40 -123.42 164.52 18.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 1.15 109.442 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.658 HG13 ' SG ' ' A' ' 186' ' ' CYS . 5.7 t -149.16 128.92 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.129 -0.982 . . . . 0.59 109.842 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 162' ' ' GLU . 19.2 m-90 -124.34 159.63 29.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 0.23 109.631 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -118.01 116.9 27.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 1.81 108.677 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.698 ' C ' HD13 ' A' ' 167' ' ' ILE . 28.4 m -128.35 174.26 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.97 -1.081 . . . . 0.46 110.45 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.778 HD12 HG23 ' A' ' 182' ' ' ILE . 3.7 mm -119.12 106.01 18.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.356 -0.979 . . . . 0.41 108.356 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 183' ' ' TYR . 1.2 mm? -45.06 157.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.601 0.715 . . . . 0.74 110.747 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 169' ' ' LYS . 2.7 tppt? -131.82 136.32 28.18 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.309 -0.997 . . . . 0.97 108.309 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.61 89.87 0.72 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.366 2.044 . . . . 0.82 110.727 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -66.31 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.74 109.788 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -137.39 -82.55 0.11 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.131 -1.188 . . . . 0.38 110.131 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.603 HD13 ' CZ ' ' A' ' 236' ' ' PHE . 12.3 mt -53.06 -29.64 31.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -1.092 . . . . 0.34 109.954 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -90.12 51.23 3.43 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.67 -1.372 . . . . 0.4 109.67 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -150.05 -45.21 0.13 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -1.079 . . . . 1.79 109.154 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.2 m -85.94 -38.21 18.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.867 . . . . 1.11 109.023 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.509 ' HB2' HD12 ' A' ' 179' ' ' LEU . 0.3 OUTLIER -89.23 -4.14 58.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.355 -0.841 . . . . 0.87 110.146 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 8.1 t30 68.15 48.55 0.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.026 . . . . 1.97 110.278 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 177' ' ' LYS . 1.9 mt -106.37 90.91 3.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.39 109.054 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 179' ' ' LEU . 10.1 pt -154.24 168.79 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -0.849 . . . . 0.56 109.647 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.25 -150.87 17.41 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.456 -1.458 . . . . 0.31 109.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.778 HG23 HD12 ' A' ' 167' ' ' ILE . 1.5 mt -103.06 113.09 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.77 109.268 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.519 ' HB2' HD23 ' A' ' 168' ' ' LEU . 23.8 m-85 -118.63 -174.8 2.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 1.27 109.828 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -140.3 124.5 17.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 2.25 109.231 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 253' ' ' ILE . 1.5 tp -84.01 91.76 7.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.28 109.481 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.658 ' SG ' HG13 ' A' ' 163' ' ' VAL . 62.4 m -87.93 110.12 20.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.152 -0.967 . . . . 1.28 109.473 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 253' ' ' ILE . 21.9 tp -79.81 113.07 17.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.266 -0.896 . . . . 0.51 109.363 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 m -99.16 46.08 0.99 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.76 109.041 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 190' ' ' LYS . 1.9 p 38.61 28.74 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 112.268 0.47 . . . . 1.36 112.268 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.651 ' HD3' ' SD ' ' A' ' 260' ' ' MET . 0.5 OUTLIER 169.35 -34.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.244 -1.021 . . . . 1.53 108.244 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 61.8 p -129.7 125.72 36.62 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.247 -0.981 . . . . 0.41 110.427 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.884 HD12 HD11 ' A' ' 211' ' ' ILE . 22.5 mt -80.11 155.08 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.895 . . . . 0.29 109.253 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 103.38 4.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.04 -1.038 . . . . 0.32 110.536 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.76 ' O ' ' HB3' ' A' ' 203' ' ' ALA . 19.9 m-85 -82.24 93.3 7.08 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.22 -0.925 . . . . 1.23 108.746 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 202' ' ' ALA . 8.2 t -96.09 137.24 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.26 110.0 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 135.29 36.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.97 109.109 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.469 ' CD1' HG22 ' A' ' 182' ' ' ILE . 0.4 OUTLIER -59.34 -29.96 68.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 1.16 109.737 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.52 37.11 1.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 2.59 109.648 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 t -134.79 -164.62 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.128 -0.983 . . . . 1.5 109.469 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -133.27 -54.78 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 3.83 109.408 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.71 161.01 17.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.58 109.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HA ' HG22 ' A' ' 195' ' ' VAL . . . -54.71 153.32 6.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.31 109.443 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 194' ' ' PHE . . . -99.86 -59.34 1.73 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.28 109.611 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.67 92.38 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 0.39 109.58 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.537 ' O ' HG21 ' A' ' 230' ' ' VAL . 60.7 t -79.36 98.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.47 109.132 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.95 -178.75 3.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.379 -0.825 . . . . 0.38 109.434 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -128.55 145.84 51.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.291 -0.881 . . . . 1.55 109.526 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.643 HD22 ' SD ' ' A' ' 257' ' ' MET . 12.5 mt -68.34 -25.8 65.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.29 109.5 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.444 ' SD ' ' HE2' ' A' ' 264' ' ' PHE . 0.0 OUTLIER -69.12 -13.96 62.72 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.095 -1.003 . . . . 1.62 110.491 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -103.4 -15.66 15.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.853 -1.154 . . . . 1.69 110.116 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.884 HD11 HD12 ' A' ' 192' ' ' ILE . 53.0 mt -74.89 113.36 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.843 -1.16 . . . . 0.55 109.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -56.99 -49.56 75.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 2.27 108.799 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.414 ' HD2' HD11 ' B' ' 491' ' ' ILE . 12.6 ptt180 -161.48 175.69 11.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.622 -0.674 . . . . 2.2 109.294 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' CYS . . . . . 0.754 ' O ' ' HB3' ' B' ' 492' ' ' ALA . 0.1 OUTLIER -143.59 120.23 11.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 1.06 108.952 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 222' ' ' PHE . . . -107.8 147.44 16.43 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.686 -1.245 . . . . 0.41 110.669 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.64 ' HE1' ' HB2' ' B' ' 492' ' ' ALA . 3.6 p-80 -130.55 67.65 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.212 -1.032 . . . . 1.54 108.212 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 18.6 t -64.14 90.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.76 -0.587 . . . . 1.4 110.602 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 246' ' ' ALA . 2.7 mt-10 64.01 -88.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.452 -0.78 . . . . 1.98 110.259 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -111.72 -21.44 11.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.722 -1.236 . . . . 1.13 110.342 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -78.43 112.72 15.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.992 -1.067 . . . . 1.27 109.681 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.447 ' CZ ' HD11 ' A' ' 223' ' ' ILE . 13.1 t80 -109.28 80.85 1.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.992 -0.744 . . . . 1.27 108.992 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 237' ' ' TRP . 38.0 p90 -87.92 161.21 17.58 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.135 -0.978 . . . . 1.3 110.14 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.447 HD11 ' CZ ' ' A' ' 221' ' ' PHE . 1.2 mt -133.15 105.33 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.389 -0.82 . . . . 1.26 109.464 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -67.92 126.33 29.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.358 -0.839 . . . . 1.27 109.324 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.92 151.0 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.518 -0.739 . . . . 0.22 109.321 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -125.5 -148.1 7.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.696 -1.362 . . . . 0.82 109.696 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -61.1 167.2 3.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -1.117 . . . . 5.09 109.535 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.6 12.55 8.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 2.0 110.397 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 232' ' ' GLY . . . -92.12 143.57 26.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.782 -1.199 . . . . 0.5 109.128 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 205' ' ' VAL . 5.8 t -53.71 -27.02 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.66 109.707 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 37.3 p -107.41 -31.57 8.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 1.13 109.472 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 229' ' ' ALA . . . 118.88 -160.48 14.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.44 -1.464 . . . . 0.36 109.44 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.68 134.86 24.86 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.952 2.435 . . . . 0.71 109.935 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 161.09 -147.26 13.67 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.182 -1.567 . . . . 0.23 109.182 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.13 145.68 18.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.209 -1.171 . . . . 1.36 109.658 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.603 ' CZ ' HD13 ' A' ' 173' ' ' LEU . 33.5 m-85 -114.05 87.5 2.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.423 -0.798 . . . . 1.27 109.193 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.433 ' CD2' ' HB3' ' A' ' 222' ' ' PHE . 29.1 m95 -79.91 154.04 28.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.46 109.918 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.67 ' SD ' HG21 ' A' ' 166' ' ' VAL . 13.3 ptp -160.52 176.93 11.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 1.51 109.116 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -128.94 144.51 51.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 1.52 109.838 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 242' ' ' ASP . 14.4 m -107.86 -163.93 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.39 109.345 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -70.08 -39.11 75.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.145 -0.972 . . . . 1.27 109.731 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.469 ' H ' HG23 ' A' ' 240' ' ' VAL . 4.4 t0 -171.81 -146.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 2.17 109.185 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -91.74 22.1 4.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.601 -1.312 . . . . 1.45 110.253 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.36 -49.65 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.938 -1.101 . . . . 0.46 108.88 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.33 -25.79 38.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 0.31 108.75 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 218' ' ' GLU . . . -78.43 -42.72 29.21 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.468 -0.938 . . . . 0.31 108.468 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -78.22 -5.43 51.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 1.83 109.216 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -96.76 -31.95 12.39 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.141 -0.975 . . . . 1.01 108.551 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' MET . . . . . . . . . . . . . 6.9 ptm -87.41 -22.97 24.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.546 -0.722 . . . . 0.52 109.457 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' HIS . . . . . 0.548 ' O ' HD23 ' A' ' 254' ' ' LEU . 0.0 OUTLIER -79.58 -31.93 41.91 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.98 -1.075 . . . . 1.4 109.417 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.442 ' HG3' ' CE1' ' A' ' 250' ' ' HIS . 5.4 mt-10 -79.12 -34.37 43.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.168 -0.957 . . . . 2.12 109.563 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.79 HG21 ' OE2' ' A' ' 162' ' ' GLU . 6.0 m -78.02 -30.47 49.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.37 109.461 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.932 HD11 HD13 ' A' ' 187' ' ' LEU . 0.4 OUTLIER -82.63 -27.32 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.43 109.621 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 250' ' ' HIS . 1.6 mm? -70.89 -28.57 64.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 1.45 109.519 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -78.06 -40.38 38.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 2.01 109.666 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.445 ' HB3' HD21 ' A' ' 187' ' ' LEU . . . -63.54 -49.52 73.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.56 109.34 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' MET . . . . . 0.643 ' SD ' HD22 ' A' ' 208' ' ' LEU . 6.4 mtm -63.61 -37.74 88.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 1.13 109.345 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -26.65 68.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 3.64 109.371 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -76.18 -23.22 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.43 109.728 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' MET . . . . . 0.651 ' SD ' ' HD3' ' A' ' 190' ' ' LYS . 0.3 OUTLIER -83.09 -58.11 2.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 1.15 109.67 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -36.13 78.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.064 -1.023 . . . . 0.88 109.785 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.66 -39.12 58.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.255 -0.903 . . . . 1.74 109.903 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.73 26.36 4.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 2.72 109.585 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . 0.444 ' HE2' ' SD ' ' A' ' 209' ' ' MET . 0.2 OUTLIER -81.13 -70.49 0.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.138 -0.976 . . . . 4.14 109.478 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 266' ' ' PRO . 0.0 OUTLIER 171.37 145.98 0.14 Allowed Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 108.7 -0.852 . . . . 7.07 108.7 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 265' ' ' ARG . 46.0 Cg_exo -55.68 -152.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 123.543 2.829 . . . . 5.62 110.855 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.678 -1.264 . . . . 10.14 109.38 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 489' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.57 0.7 . . . . 1.04 109.491 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 490' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.82 115.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.86 108.907 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 491' ' ' ILE . . . . . 0.493 HD13 ' O ' ' B' ' 492' ' ' ALA . 0.0 OUTLIER -126.84 158.53 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.146 -0.971 . . . . 0.77 110.049 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 492' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 214' ' ' CYS . . . -133.48 -176.39 4.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 1.25 108.966 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 493' ' ' GLY . . . . . . . . . . . . . . . -132.38 166.1 23.47 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.502 -1.332 . . . . 0.72 109.958 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 494' ' ' ASN . . . . . 0.615 ' OD1' ' SD ' ' A' ' 257' ' ' MET . 1.1 t30 -109.24 113.37 58.81 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.441 -1.035 . . . . 0.74 108.834 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 495' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.31 -38.9 2.36 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.575 2.183 . . . . 0.35 111.221 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 496' ' ' ALA . . . . . 0.484 ' CB ' ' HE3' ' A' ' 260' ' ' MET . . . -75.39 -0.73 20.93 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.038 -1.039 . . . . 0.48 111.494 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 497' ' ' PTR . . . . . 0.445 ' HB3' ' HB3' ' B' ' 494' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 498' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 72.84 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.7 -0.625 . . . . 2.85 110.433 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 499' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 120.549 -1.344 . . . . 2.79 109.554 -179.954 . . . . . . . . 1 1 . 1 stop_ save_